{
  "node_id": "fda-21-cfr-part-600-601-biologics-licensing",
  "title": "Biological Products: General; and Licensing",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.1",
  "last_updated": "2026-04-30",
  "bluf": "The FDA 21 CFR Parts 600-601 regulation requires manufacturers of biological products to submit a Biologics License Application (BLA) and comply with lot release testing and approval…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "nist_framework",
      "iso_standard",
      "industry_mapping",
      "ai_overlay_2026"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "primary_citations_count": 6,
  "workflow_steps_count": 10,
  "schema_fields_count": 6,
  "citation_preview": [
    "21 CFR Part 600, Section 600.3 - Lot Release Requirements",
    "21 CFR Part 601, Section 601.2 - Biologics License Application"
  ]
}